# Detection of Brain Metastases Using a Novel Gadolinium-Weighted MRI Sequence: A Prospective Comparison

> **NCT07272616** · — · RECRUITING · sponsor: **Region Stockholm** · enrollment: 100 (estimated)

## Conditions studied

- Brain Neoplasms

## Interventions

- **DIAGNOSTIC_TEST:** Novel Gadolinium-Weighted MRI Sequence

## Key facts

- **NCT ID:** NCT07272616
- **Lead sponsor:** Region Stockholm
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-28
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07272616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07272616, "Detection of Brain Metastases Using a Novel Gadolinium-Weighted MRI Sequence: A Prospective Comparison". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT07272616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*